NRDC licences Anti diabetic Drug
New Delhi: A License Agreement for commercialization of Ayush-82, an ayurvedic formulation for prevention and management of Diabetes developed by Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, apex organization for research in Ayurveda in India under the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy), Govt. of India was signed and exchanged between Dr. H. Purushotham Chairman & Managing Director, National Research Development Corporation, an Enterprise of the Department of Scientific & Industrial Research, Ministry of Science & Technology, Govt. of India, New Delhi (NRDC) and Shri Sanjay Kumar Garg, Propritor of M/s Herbal Ayurveda and Reserch Centre, Faridabad at NRDC in presence of Dr. Girish Sahni, DG, CSIR and Secretary DSIR. S/Shri Ashwani Gupta and B.N. Sarkar, Scientist `G’, DSIR and Senior officers of NRDC were also present during the event. Dr. H. Purushotham said that patients prefer off late Ayurvedic drugs as it can be seen that till date NRDC licensed this technology to 12 companies in India.
Read Also : CIL’s capex up 6.5% to highest Rs.19,840 Crores in FY 2024News Must Read
- SCOPE presents SCOPE PREMIER LEAGUE
- MCL Ib Valley Washery commenced commercial operation
- HAL bags Rs 65,000 Cr tender by Defence Ministry
- PSBs' growth output superseded Private Lending firms
- Northern Coalfields Limited CMD inspects Amlohri Area
- SCOPE organizes Public Sector Day celebrations
- IOCL Final Dividend Announcement Expected at April 30 Board Meeting
- Steel Cutting Ceremony of Indian Navy held at HSL Vishakapatnam
- DIPAM declines PFC-REC debt resolution proposal for KSK Mahanadi project
- Govt extends deadline for submission of R&D Proposals under National Green Hydrogen Mission